ISOALANTOLACTONE, (±)-

C[C@]12CCCC(=C)[C@@H]1C[C@H]3[C@@H](C2)OC(=O)C3=C

InChIKey=CVUANYCQTOGILD-QVHKTLOISA-N

InChI=1S/C15H20O2/c1-9-5-4-6-15(3)8-13-11(7-12(9)15)10(2)14(16)17-13/h11-13H,1-2,4-8H2,3H3/t11-,12+,13-,15-/m1/s1

Targets

Primary Target	Pharmacology	Condition	Potency
NF-kappa B signaling pathway 87 Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25109871	Inhibitor 8504

PubMed

Title	Date	PubMed
Isoalantolactone inhibits constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction.	2014-10	25109871

Name

Type

Language

ISOALANTOLACTONE, (±)-

Common Name

English

(±)-ISOALANTOLACTONE

Preferred Name

English

EUDESMA-4(14),11(13)-DIEN-12-OIC ACID, 8.BETA.-HYDROXY-, .GAMMA.-LACTONE, (±)-

Common Name

English

REL-(3AR,4AS,8AR,9AR)-DECAHYDRO-8A-METHYL-3,5-BIS(METHYLENE)NAPHTHO(2,3-B)FURAN-2(3H)-ONE

Common Name

English

NAPHTHO(2,3-B)FURAN-2(3H)-ONE, DECAHYDRO-8A-METHYL-3,5-BIS(METHYLENE)-, (3AR,4AS,8AR,9AR)-REL-

Systematic Name

English

Code System Code Type Description

FDA UNII

QTF89ZHT7V

Created by admin on Wed Apr 02 10:28:20 GMT 2025 , Edited by admin on Wed Apr 02 10:28:20 GMT 2025

PRIMARY

CAS

107439-69-0

Created by admin on Wed Apr 02 10:28:20 GMT 2025 , Edited by admin on Wed Apr 02 10:28:20 GMT 2025

SUPERSEDED

CAS

4677-48-9

Created by admin on Wed Apr 02 10:28:20 GMT 2025 , Edited by admin on Wed Apr 02 10:28:20 GMT 2025

PRIMARY

SUBSTANCE RECORD


					QTF89ZHT7V